Phase 1 clinical trials of the safety and immunogenicity of adjuvanted plasmid DNA vaccines encoding influenza A virus H5 hemagglutinin.

Smith, Larry R; Wloch, Mary K; Ye, Ming; Reyes, Luane R; Boutsaboualoy, Souphaphone; Dunne, Casey E; Chaplin, Jennifer A; Rusalov, Denis; Rolland, Alain P; Fisher, Cindy L; Al-Ibrahim, Mohamed S; Kabongo, Martin L; Steigbigel, Roy; Belshe, Robert B; Kitt, Ernest R; Chu, Alice H; Moss, Ronald B

Smith, Larry R; Wloch, Mary K; Ye, Ming; Reyes, Luane R; Boutsaboualoy, Souphaphone; Dunne, Casey E; Chaplin, Jennifer A; Rusalov, Denis; Rolland, Alain P; Fisher, Cindy L; Al-Ibrahim, Mohamed S; Kabongo, Martin L; Steigbigel, Roy; Belshe, Robert B; Kitt, Ernest R; Chu, Alice H; Moss, Ronald B.

Affiliation

Smith LR; Vical Incorporated, 10390 Pacific Center Court, San Diego, CA 92121, United States. lsmith@vical.com

Vaccine ; 28(13): 2565-72, 2010 Mar 16.

Article in En | MEDLINE | ID: mdl-20117262

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Influenza A virus / Influenza Vaccines / Vaccines, DNA / Hemagglutinin Glycoproteins, Influenza Virus Type of study: Clinical_trials Limits: Adult / Female / Humans / Male Language: En Journal: Vaccine Year: 2010 Document type: Article Affiliation country: Country of publication:

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google